Fund shareholders of Revolution Medicines Inc
ISIN US76155X1000 · United States · LEI 549300JU3X0LBCQ65892
- Fund shareholders
- 420
- Of which ETFs
- 98 322 other funds
- Value held
- 5.1B $ 404.1M SEK · 677.8K €
- Share of capital
- 22.6 % of 214.3M shares on Jul 31, 2026
This issuer has other securities : REVOLUTION MEDICINES INC WTS 12/26 (US76155X1182)
420 funds hold this company. This table lists the 419 that declare it in a regulatory filing. 1 more fund publishes its holdings in its own report. It is not in the table.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| JNL/T. Rowe Price Mid-Cap Growth Fund JNL Series Trust | 63,800 | 6.2M $ | 0.15 % | 0.03 % | as of Mar 31, 2026 ↗ |
| iShares Russell 2500 ETF iShares Trust | 63,446 | 6.2M $ | 0.24 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Schwab 1000 Index Fund SCHWAB INVESTMENTS | 62,616 | 9M $ | 0.04 % | 0.03 % | as of Apr 30, 2026 ↗ |
| John Hancock Multifactor Mid Cap ETF John Hancock Exchange-Traded Fund Trust | 62,464 | 6.1M $ | 0.12 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Large Cap Value Index Fund Fidelity Salem Street Trust | 62,057 | 8.9M $ | 0.08 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Handelsbanken Global Småbolag Index Criteria Handelsbanken Fonder AB | 61,775 | 57.2M SEK | 0.20 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Strategic Advisers U.S. Total Stock Fund Fidelity Rutland Square Trust II | 60,870 | 6.2M $ | 0.01 % | 0.03 % | as of Feb 28, 2026 ↗ |
| STATE STREET SMALL/MID CAP EQUITY INDEX PORTFOLIO STATE STREET INSTITUTIONAL INVESTMENT TRUST | 60,544 | 5.9M $ | 0.22 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Six Circles Managed Equity Portfolio U.S. Unconstrained Fund SIX CIRCLES TRUST | 58,973 | 5.7M $ | 0.02 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Invesco Health Care Fund AIM Investment Funds (Invesco Investment Funds) | 58,564 | 8.4M $ | 0.75 % | 0.03 % | as of Apr 30, 2026 ↗ |
| U.S. CORE EQUITY 1 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 57,467 | 8.3M $ | 0.02 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Victory RS Small Cap Growth Fund Victory Portfolios | 55,170 | 5.4M $ | 1.61 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs ActiveBeta(R) U.S. Large Cap Equity ETF Goldman Sachs ETF Trust | 51,704 | 5.3M $ | 0.04 % | 0.02 % | as of Feb 28, 2026 ↗ |
| Six Circles U.S. Unconstrained Equity Fund SIX CIRCLES TRUST | 51,190 | 5M $ | 0.02 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Fidelity ZERO Large Cap Index Fund Fidelity Concord Street Trust | 50,444 | 7.3M $ | 0.04 % | 0.02 % | as of Apr 30, 2026 ↗ |
| JNL Multi-Manager Small Cap Growth Fund JNL Series Trust | 50,363 | 4.9M $ | 0.25 % | 0.02 % | as of Mar 31, 2026 ↗ |
| JPMorgan U.S. Momentum Factor ETF J.P. Morgan Exchange-Traded Fund Trust | 49,923 | 7.2M $ | 0.33 % | 0.02 % | as of Apr 30, 2026 ↗ |
| Direxion Daily S&P Biotech Bull 3X Shares Direxion Shares ETF Trust | 48,748 | 7M $ | 1.35 % | 0.02 % | as of Apr 30, 2026 ↗ |
| HealthInvest Sustainable Healthcare Atle Fund Management AB | 48,646 | 44.8M SEK | 1.41 % | 0.02 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Integrated U.S. Small-Mid Cap Core Equity Fund T. ROWE PRICE INTEGRATED EQUITY FUNDS, INC. | 46,982 | 4.6M $ | 0.32 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index ETF Fidelity Commonwealth Trust | 46,447 | 4.7M $ | 0.05 % | 0.02 % | as of Feb 28, 2026 ↗ |
| iShares Russell 3000 ETF iShares Trust | 46,145 | 4.5M $ | 0.03 % | 0.02 % | as of Mar 31, 2026 ↗ |
| NICHOLAS PARTNERS SMALL CAP GROWTH FUND ADVISORS' INNER CIRCLE III | 45,757 | 4.4M $ | 2.98 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Dimensional U.S. Equity Market ETF Dimensional ETF Trust | 44,720 | 6.4M $ | 0.03 % | 0.02 % | as of Apr 30, 2026 ↗ |
| HealthInvest Small & Mid Cap Healthcare Atle Fund Management AB | 44,691 | 41.2M SEK | 4.13 % | 0.02 % | as of Mar 31, 2026 ↗ |
| iShares ESG Aware MSCI USA Small-Cap ETF iShares Trust | 44,669 | 4.6M $ | 0.19 % | 0.02 % | as of Feb 28, 2026 ↗ |
| iShares MSCI ACWI ETF iShares Trust | 44,468 | 6.4M $ | 0.02 % | 0.02 % | as of Apr 30, 2026 ↗ |
| Goldman Sachs Small Cap Value Fund Goldman Sachs Trust | 44,038 | 4.5M $ | 0.48 % | 0.02 % | as of Feb 28, 2026 ↗ |
| ALGER CAPITAL APPRECIATION INSTITUTIONAL FUND ALGER INSTITUTIONAL FUNDS | 43,913 | 6.3M $ | 0.19 % | 0.02 % | as of Apr 30, 2026 ↗ |
| ALGER SPECTRA FUND ALGER FUNDS II | 43,082 | 6.2M $ | 0.14 % | 0.02 % | as of Apr 30, 2026 ↗ |
| Goldman Sachs Mid Cap Growth Fund Goldman Sachs Trust | 42,206 | 4.3M $ | 0.44 % | 0.02 % | as of Feb 28, 2026 ↗ |
| Transamerica Janus Mid-Cap Growth VP TRANSAMERICA SERIES TRUST | 40,806 | 4M $ | 0.47 % | 0.02 % | as of Mar 31, 2026 ↗ |
| VANGUARD U.S. MOMENTUM FACTOR ETF VANGUARD WELLINGTON FUND | 40,724 | 4.2M $ | 0.30 % | 0.02 % | as of Feb 28, 2026 ↗ |
| Mercer US Small/Mid Cap Equity Fund Mercer Funds | 39,980 | 3.9M $ | 0.23 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Victory RS Science & Technology Fund Victory Portfolios | 39,270 | 3.8M $ | 2.02 % | 0.02 % | as of Mar 31, 2026 ↗ |
| iShares Morningstar Small-Cap Growth ETF iShares Trust | 39,258 | 5.7M $ | 0.60 % | 0.02 % | as of Apr 30, 2026 ↗ |
| VANGUARD ESG U.S. STOCK ETF VANGUARD WORLD FUND | 38,451 | 3.9M $ | 0.03 % | 0.02 % | as of Feb 28, 2026 ↗ |
| Fidelity Advisor Mid Cap II Fund Fidelity Advisor Series I | 38,000 | 3.7M $ | 0.22 % | 0.02 % | as of Mar 31, 2026 ↗ |
| HARTFORD SMALL COMPANY HLS FUND HARTFORD SERIES FUND INC | 37,909 | 3.7M $ | 0.95 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Small Cap Growth Fund VALIC Co I | 37,123 | 3.8M $ | 0.70 % | 0.02 % | as of Feb 28, 2026 ↗ |
| SEB Läkemedelsfond SEB Funds AB | 36,214 | 33.5M SEK | 0.21 % | 0.02 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Institutional Mid-Cap Equity Growth Fund T. Rowe Price Equity Funds, Inc. | 36,200 | 3.5M $ | 0.13 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Dimensional U.S. Small Cap ETF Dimensional ETF Trust | 35,880 | 5.2M $ | 0.04 % | 0.02 % | as of Apr 30, 2026 ↗ |
| ALGER CAPITAL APPRECIATION FUND ALGER FUNDS | 35,743 | 5.2M $ | 0.19 % | 0.02 % | as of Apr 30, 2026 ↗ |
| Schwab U.S. Mid-Cap Index Fund SCHWAB CAPITAL TRUST | 34,338 | 4.9M $ | 0.19 % | 0.02 % | as of Apr 30, 2026 ↗ |
| Goldman Sachs Equal Weight U.S. Large Cap Equity ETF Goldman Sachs ETF Trust | 34,043 | 3.5M $ | 0.21 % | 0.02 % | as of Feb 28, 2026 ↗ |
| Small-Cap Growth Portfolio PACIFIC SELECT FUND | 32,663 | 3.2M $ | 0.72 % | 0.02 % | as of Mar 31, 2026 ↗ |
| T.Rowe Price Small Cap Growth Portfolio Brighthouse Funds Trust II | 32,614 | 3.2M $ | 0.30 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Health Sciences Trust John Hancock Variable Insurance Trust | 32,474 | 3.2M $ | 1.39 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Focused Growth Portfolio PACIFIC SELECT FUND | 31,993 | 3.1M $ | 0.70 % | 0.01 % | as of Mar 31, 2026 ↗ |
| iShares Russell Mid-Cap Index Fund BlackRock Funds | 31,883 | 4.6M $ | 0.19 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Calvert U.S. Large Cap Value Responsible Index Fund Calvert Responsible Index Series, Inc. | 31,704 | 3.1M $ | 0.17 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs Small Cap Growth Fund Goldman Sachs Trust | 30,348 | 3.1M $ | 0.73 % | 0.01 % | as of Feb 28, 2026 ↗ |
| BNY Mellon US Mid Cap Core Equity ETF BNY Mellon ETF Trust | 29,535 | 4.3M $ | 0.69 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Dimensional US Core Equity Market ETF Dimensional ETF Trust | 29,405 | 4.2M $ | 0.04 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Empower T. Rowe Price Mid Cap Growth Fund EMPOWER FUNDS, INC. | 29,300 | 2.8M $ | 0.15 % | 0.01 % | as of Mar 31, 2026 ↗ |
| VANGUARD RUSSELL 1000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 28,962 | 3M $ | 0.03 % | 0.01 % | as of Feb 28, 2026 ↗ |
| Fidelity Mid Cap Value Index Fund Fidelity Salem Street Trust | 28,916 | 2.8M $ | 0.17 % | 0.01 % | as of Mar 31, 2026 ↗ |
| iShares Russell Small/Mid-Cap Index Fund BlackRock Funds | 28,427 | 4.1M $ | 0.33 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Small Cap Growth Stock Portfolio NORTHWESTERN MUTUAL SERIES FUND INC | 28,046 | 2.7M $ | 0.37 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Tax-Managed U.S. Mid & Small Cap Fund RUSSELL INVESTMENT CO | 27,226 | 3.9M $ | 0.19 % | 0.01 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Extended Equity Market Index Fund T. ROWE PRICE INDEX TRUST, INC. | 27,020 | 2.6M $ | 0.26 % | 0.01 % | as of Mar 31, 2026 ↗ |
| SIIT EXTENDED MARKET INDEX FUND SEI INSTITUTIONAL INVESTMENTS TRUST | 26,703 | 2.7M $ | 0.22 % | 0.01 % | as of Feb 28, 2026 ↗ |
| Columbia Variable Portfolio - Acorn Fund COLUMBIA FUNDS VARIABLE SERIES TRUST | 26,194 | 2.5M $ | 0.59 % | 0.01 % | as of Mar 31, 2026 ↗ |
| MassMutual Mid Cap Growth Fund MASSMUTUAL SELECT FUNDS | 25,000 | 2.4M $ | 0.09 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Fidelity Enhanced Mid Cap ETF Fidelity Covington Trust | 24,618 | 2.4M $ | 0.04 % | 0.01 % | as of Mar 31, 2026 ↗ |
| THE HARTFORD SMALL COMPANY FUND HARTFORD MUTUAL FUNDS, INC | 24,480 | 3.5M $ | 0.53 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Small Cap Stock Trust John Hancock Variable Insurance Trust | 24,363 | 2.4M $ | 0.96 % | 0.01 % | as of Mar 31, 2026 ↗ |
| NYLI Candriam U.S. Mid Cap Equity ETF New York Life Investments ETF Trust | 24,083 | 3.5M $ | 1.10 % | 0.01 % | as of Apr 30, 2026 ↗ |
| THE HARTFORD HEALTHCARE FUND HARTFORD MUTUAL FUNDS, INC | 23,937 | 3.4M $ | 0.47 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Fidelity Series All-Sector Equity Fund Fidelity Devonshire Trust | 23,900 | 3.4M $ | 0.06 % | 0.01 % | as of Apr 30, 2026 ↗ |
| MassMutual Small Cap Growth Equity Fund MASSMUTUAL SELECT FUNDS | 23,718 | 2.3M $ | 0.41 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Morgan Stanley Pathway Small-Mid Cap Equity ETF MORGAN STANLEY PATHWAY FUNDS | 23,621 | 2.4M $ | 0.33 % | 0.01 % | as of Feb 28, 2026 ↗ |
| Biotechnology Fund Rydex Series Funds | 23,475 | 2.3M $ | 1.69 % | 0.01 % | as of Mar 31, 2026 ↗ |
| LVIP T. Rowe Price Structured Mid-Cap Growth Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 23,126 | 2.2M $ | 0.17 % | 0.01 % | as of Mar 31, 2026 ↗ |
| EQ/T.Rowe Price Health Sciences Portfolio EQ Advisors Trust | 22,862 | 2.2M $ | 1.40 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Brighthouse/Wellington Large Cap Research Portfolio Brighthouse Funds Trust I | 21,290 | 2.1M $ | 0.09 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Transamerica T. Rowe Price Small Cap VP TRANSAMERICA SERIES TRUST | 21,228 | 2.1M $ | 0.33 % | 0.01 % | as of Mar 31, 2026 ↗ |
| EQ/Common Stock Index Portfolio EQ Advisors Trust | 20,724 | 2M $ | 0.03 % | 0.01 % | as of Mar 31, 2026 ↗ |
| HARTFORD SMALL CAP GROWTH HLS FUND HARTFORD SERIES FUND INC | 20,428 | 2M $ | 0.38 % | 0.01 % | as of Mar 31, 2026 ↗ |
| SA Janus Focused Growth Portfolio SUNAMERICA SERIES TRUST | 20,107 | 2.9M $ | 0.58 % | 0.01 % | as of Apr 30, 2026 ↗ |
| DWS Small Mid Cap Value VIP DEUTSCHE DWS VARIABLE SERIES II | 19,994 | 1.9M $ | 2.34 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Victory Extended Market Index Fund Victory Portfolios III | 19,788 | 2.9M $ | 0.36 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Janus Henderson Global Research Portfolio JANUS ASPEN SERIES | 19,777 | 1.9M $ | 0.20 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs Small Cap Equity ETF Goldman Sachs ETF Trust | 19,731 | 2M $ | 1.23 % | 0.01 % | as of Feb 28, 2026 ↗ |
| Mid Cap Strategic Growth Fund VALIC Co I | 19,646 | 2M $ | 0.18 % | 0.01 % | as of Feb 28, 2026 ↗ |
| Pinnacle Focused Opportunities ETF Tidal Trust II | 19,367 | 2M $ | 3.15 % | 0.01 % | as of Feb 28, 2026 ↗ |
| Avantis U.S. Equity ETF American Century ETF Trust | 19,211 | 2M $ | 0.02 % | 0.01 % | as of Feb 28, 2026 ↗ |
| BlackRock Advantage SMID Cap Fund, Inc. BlackRock Advantage SMID Cap Fund, Inc. | 18,633 | 1.8M $ | 0.24 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Health Sciences Portfolio PACIFIC SELECT FUND | 18,010 | 1.8M $ | 0.49 % | 0.01 % | as of Mar 31, 2026 ↗ |
| VIP Health Care Portfolio Variable Insurance Products Fund IV | 18,000 | 1.8M $ | 0.17 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Calvert U.S. Large Cap Core Responsible Index Fund Calvert Responsible Index Series, Inc. | 17,907 | 1.7M $ | 0.03 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Invesco Dorsey Wright SmallCap Momentum ETF Invesco Exchange-Traded Fund Trust II | 17,806 | 1.8M $ | 0.47 % | 0.01 % | as of Feb 28, 2026 ↗ |
| ALGER MID CAP FOCUS FUND ALGER FUNDS | 17,473 | 2.5M $ | 0.79 % | 0.01 % | as of Apr 30, 2026 ↗ |
| CTIVP - Westfield Mid Cap Growth Fund Columbia Funds Variable Series Trust II | 16,970 | 1.7M $ | 0.68 % | 0.01 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Mid Cap Growth Portfolio Brighthouse Funds Trust I | 16,500 | 1.6M $ | 0.15 % | 0.01 % | as of Mar 31, 2026 ↗ |
| iShares U.S. Tech Breakthrough Multisector ETF iShares Trust | 16,300 | 2.3M $ | 0.52 % | 0.01 % | as of Apr 30, 2026 ↗ |
| VANGUARD TAX-MANAGED BALANCED FUND VANGUARD TAX-MANAGED FUNDS | 16,182 | 1.6M $ | 0.01 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Bridge Builder Large Cap Growth Fund Bridge Builder Trust | 16,013 | 1.6M $ | 0.01 % | 0.01 % | as of Mar 31, 2026 ↗ |
| VY(R) T. ROWE PRICE DIVERSIFIED MID CAP GROWTH PORTFOLIO Voya Partners Inc | 15,912 | 1.5M $ | 0.18 % | 0.01 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| iShares Genomics Immunology and Healthcare ETF iShares Trust | 6.85 % | as of Apr 30, 2026 ↗ |
| Tema Oncology ETF Tema ETF Trust | 6.29 % | as of Feb 28, 2026 ↗ |
| HealthInvest Small & Mid Cap Healthcare Atle Fund Management AB | 4.13 % | as of Mar 31, 2026 ↗ |
| Marsico Midcap Growth Focus Fund MARSICO INVESTMENT FUND | 3.22 % | as of Mar 31, 2026 ↗ |
| Pinnacle Focused Opportunities ETF Tidal Trust II | 3.15 % | as of Feb 28, 2026 ↗ |
| NICHOLAS PARTNERS SMALL CAP GROWTH FUND ADVISORS' INNER CIRCLE III | 2.98 % | as of Mar 31, 2026 ↗ |
| VanEck Biotech ETF VanEck ETF Trust | 2.86 % | as of Mar 31, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 2.82 % | as of Apr 30, 2026 ↗ |
| Janus Henderson Transformational Growth ETF Janus Detroit Street Trust | 2.41 % | as of Apr 30, 2026 ↗ |
| Harbor Health Care ETF Harbor ETF Trust | 2.38 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 400 | +41 | 47,949,343 | -6.1 % |
| 2026Q1 | 359 | +41 | 51,041,234 | -8.6 % |
| 2025Q4 | 318 | -18 | 55,857,845 | -6.5 % |
| 2025Q3 | 336 | +10 | 59,732,762 | -7.8 % |
| 2025Q2 | 326 | +4 | 64,794,405 | +3.7 % |
| 2025Q1 | 322 | +9 | 62,505,392 | +5.6 % |
| 2024Q4 | 313 | +26 | 59,209,688 | +5.5 % |
| 2024Q3 | 287 | +20 | 56,129,869 | +4.9 % |
| 2024Q2 | 267 | +18 | 53,490,879 | +17.6 % |
| 2024Q1 | 249 | +26 | 45,498,077 | +12.7 % |
| 2023Q4 | 223 | 40,365,735 |
Institutional managers
503 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT LLC | 13,604,796 | 1.3B $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 11,212,706 | 1.1B $ | as of Mar 31, 2026 |
| JANUS HENDERSON GROUP PLC | 9,766,496 | 949.5M $ | as of Mar 31, 2026 |
| BAKER BROS. ADVISORS LP | 9,555,357 | 929.3M $ | as of Mar 31, 2026 |
| FMR LLC | 8,464,314 | 823.2M $ | as of Mar 31, 2026 |
| Nextech Invest, Ltd. | 7,601,087 | 739.2M $ | as of Mar 31, 2026 |
| Paradigm Biocapital Advisors LP | 6,655,703 | 647.3M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 6,027,819 | 586.2M $ | as of Mar 31, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,475,611 | 532.5M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 4,402,662 | 428.2M $ | as of Mar 31, 2026 |
| UBS Group AG | 4,386,791 | 426.6M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 3,338,142 | 323.9M $ | as of Mar 31, 2026 |
| Alphabet Inc. | 3,292,525 | 320.2M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 3,232,213 | 314.3K $ | as of Mar 31, 2026 |
| BVF INC/IL | 2,856,782 | 277.8M $ | as of Mar 31, 2026 |
| Casdin Capital, LLC | 2,577,333 | 250.6M $ | as of Mar 31, 2026 |
| Woodline Partners LP | 2,506,570 | 243.8M $ | as of Mar 31, 2026 |
| Holocene Advisors, LP | 2,468,644 | 240.1M $ | as of Mar 31, 2026 |
| Vestal Point Capital, LP | 2,375,000 | 231M $ | as of Mar 31, 2026 |
| Avoro Capital Advisors LLC | 2,344,444 | 228M $ | as of Mar 31, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 2,297,000 | 223.4M $ | as of Mar 31, 2026 |
| Darwin Global Management, Ltd. | 2,211,018 | 205M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 2,185,500 | 212.5M $ | as of Mar 31, 2026 |
| Logos Global Management LP | 2,000,000 | 194.5M $ | as of Mar 31, 2026 |
| Alyeska Investment Group, L.P. | 1,885,821 | 183.4M $ | as of Mar 31, 2026 |
Declared shareholders of Revolution Medicines Inc
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 4.90 % | 9,766,496 | as of Mar 31, 2026 · SCHEDULE 13G |
Funds holding the debt of Revolution Medicines Inc
12 funds declare 12 bond lines of this company. The amount is the one the fund files. It is not a share of the debt, because no regulator publishes the amount outstanding in open access.
| Fund | Bond lines | Value | |
|---|---|---|---|
| NYLI MacKay Convertible Fund | 1 | 18.9M $ | as of Apr 30, 2026 |
| Calamos Growth & Income Fund | 1 | 12.3M $ | as of Apr 30, 2026 |
| Calamos Market Neutral Income Fund | 1 | 6M $ | as of Apr 30, 2026 |
| Calamos Convertible Fund | 1 | 5M $ | as of Apr 30, 2026 |
| Putnam Convertible Securities Fund | 1 | 4.6M $ | as of Apr 30, 2026 |
| iShares Convertible Bond ETF | 1 | 3.3M $ | as of Apr 30, 2026 |
| Calamos Global Opportunities Fund | 1 | 1.6M $ | as of Apr 30, 2026 |
| Miller Market Neutral Income Fund | 1 | 753K $ | as of Apr 30, 2026 |
| First Trust SSI Strategic Convertible Securities ETF | 1 | 568.2K $ | as of Apr 30, 2026 |
| Calamos Global Convertible Fund | 1 | 402K $ | as of Apr 30, 2026 |
| Janus Henderson Income ETF | 1 | 344.5K $ | as of Apr 30, 2026 |
| Miller Convertible Total Return ETF | 1 | 55.8K $ | as of Apr 30, 2026 |
Cite this page
Titelia. "Fund shareholders of Revolution Medicines Inc". https://titelia.com/en/stocks/revolution-medicines-inc-US76155X1000